OUR PRODUCTS

MOBILE APPS

GENERAL INFO

GRCL

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Gracell Biotechnologies (GRCL) Ownership - Who owns Gracell Biotechnologies?

Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfill unmet medical needs in the treatment of cancer... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

218 Sangtian Street

Phone

+86 51262626701

Employees

314

Web

https://www.gracellbio.com

Details

Group

Domestic Stock Funds

Fundamentals

GRCL

Capitalization

N/A

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

N/A

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

N/A

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

N/A

Shares Outstanding - Current

N/A

Total Liabilities

N/A

Total Volume MTD

N/A

Value

N/A

Gain YTD

N/A

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for GRCL (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

Industry Biotechnology